SummaryThe objective of this research was to evaluate, in the laboratory, the potential of gas chromatography/ion mobility spectrometry (GC/IMS) for monitoring vinyl chloride and other organic compounds in air samples in the field. It was determined that GC/IMS has the potential to directly detect vinyl chloride in air at the 2 ppbv level, and when concentrated on an adsorbent trap from a 1 L sample of air, detection could be lowered to the 0.02 ppbv level. From a comparative investigation of 18 EPA priority pollutants and 34 common vapor-phase organic compounds, many compounds were found to provide a more sensitive response in IMS than vinyl chloride, indicating that GC/IMS would he broadly applicable to the direct detection of vapor-phase organics in air.Operating parameters including drift gas, spectrometer temperature, and sample-inlet position were evaluated and discussed with respect to sensitivity and resolution. High temperature dramatically increased sensitivity to vinyl chloride. Vinyl chloride was shown to produce both negative and positive ion mobility spectra, with the negative-mode spectra resulting from electron-capture dissociation of the vinyl chloride. The limit of detection for vinyl chloride was found to be 7 pg/s. Limits of detection for 18 EPA priority pollutants were determined and compared to vinyl chloride. The responses of 34 other vapor-phase organic compounds were also compared to that of vinyl chloride. Non-selective, positive-ion detection of 30 of the 34 compounds was demonstrated along with selective, electron-capture-type detection of 29 of them. Chloride-specific and bromide-specific detection illustrated the advantages of selected-ion monitoring in IMS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.